| First Author | Abe Y | Year | 2018 |
| Journal | Life Sci Alliance | Volume | 1 |
| Issue | 6 | Pages | e201800062 |
| PubMed ID | 30519675 | Mgi Jnum | J:286468 |
| Mgi Id | MGI:6391670 | Doi | 10.26508/lsa.201800062 |
| Citation | Abe Y, et al. (2018) Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum. Life Sci Alliance 1(6):e201800062 |
| abstractText | Peroxisome biogenesis disorders (PBDs) manifest as neurological deficits in the central nervous system, including neuronal migration defects and abnormal cerebellum development. However, the mechanisms underlying pathogenesis remain enigmatic. Here, to investigate how peroxisome deficiency causes neurological defects of PBDs, we established a new PBD model mouse defective in peroxisome assembly factor Pex14p, termed Pex14 (DeltaC/DeltaC) mouse. Pex14 (DeltaC/DeltaC) mouse manifests a severe symptom such as disorganization of cortical laminar structure and dies shortly after birth, although peroxisomal biogenesis and metabolism are partially defective. The Pex14 (DeltaC/DeltaC) mouse also shows malformation of the cerebellum including the impaired dendritic development of Purkinje cells. Moreover, extracellular signal-regulated kinase and AKT signaling are attenuated in this mutant mouse by an elevated level of brain-derived neurotrophic factor (BDNF) together with the enhanced expression of TrkB-T1, a dominant-negative isoform of the BDNF receptor. Our results suggest that dysregulation of the BDNF-TrkB pathway, an essential signaling for cerebellar morphogenesis, gives rise to the pathogenesis of the cerebellum in PBDs. |
